Clinical trial

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

NCT00296374

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Rosuvastatin Normalized identity: rosuvastatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Atorvastatin Normalized identity: atorvastatinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-02-01

PhasePHASE2

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

RosuvastatinDRUG · verified · RxNorm: rosuvastatin

AtorvastatinDRUG · verified · RxNorm: atorvastatin

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

HoustonTexas, United States1 DallasTexas, United States1 St LouisMissouri, United States1 San AntonioTexas, United States1 ParisFrance1 PittsburghPennsylvania, United States1 CincinnatiOhio, United States1 MontrealQuebec, Canada1 PhoenixArizona, United States1 JacksonvilleFlorida, United States1 DetroitMichigan, United States1 MilanItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00296374 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.